Core C: Enzymology Core
Core C: Enzymology Core
批准号:
10513682
负责人:
CRAIG E. CAMERON
金额:
$746.26万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-16 至 2025-04-30
关键词:
Alberta provinceAlphavirusBacteriaBinding SitesBiochemicalBiochemistryBiological AssayBiophysicsCOVID-19 assayCellsCollaborationsCommunitiesComplexCoronavirusCryoelectron MicroscopyDevelopmentDistantEbola virusEnzymatic BiochemistryEnzyme InhibitionEnzyme KineticsEnzymesExhibitsFilovirusFlavivirusGenerationsGoalsHIV-1InsectaInternationalLaboratoriesLeadMammalian CellMeasurementMiniaturizationMonitorMultienzyme ComplexesMultiprotein ComplexesMutationNucleotidesPolymeraseProcessProtein FamilyRNA HelicaseRNA-Directed DNA PolymeraseRecordsResearch Project GrantsResistanceResistance developmentReverse Transcriptase InhibitorsSARS coronavirusStructureSystemTechnologyTestingTranslationsUniversitiesValidationViralVirusX-Ray Crystallographyantiviral drug developmentbiophysical techniquesdensitydrug developmentdrug discoveryhigh throughput screeninginhibitorinsightinterestlead optimizationmemberprogramsprotein expressionprotein purificationprotocol developmentscreeningsingle moleculestructural biologythree dimensional structuretoolvirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The overarching goal of Core C is to support READDI-AC discovery efforts in collaboration with Discovery Core
B and MedChem Core D by validation, characterization, and optimization of compounds in enzyme assays and
structural studies, and to provide the Research Projects with detailed mechanisms of action and mechanistic
insights to mitigate potential problems with resistance conferring mutations.
Enzymology Core C includes seven internationally recognized laboratories that cover complementary expertise
at the interfaces of virology, biochemistry, biophysics and structural biology. Three specific aims that describe
the central activities of Enzymology Core C:
Aim 1: Develop assays to support hit discovery efforts by Discovery Core B.
Key activities include the expression and purification of enzymes that the Research Projects and Discovery
Core B have selected as targets. Enzymology Core C will support the development of protocols for the
expression and purification of new enzyme targets and their corresponding assays to monitor activity and
inhibition. The translation of enzyme assays into high density formats to facilitate high throughput screening by
Discovery Core B is a second responsibility.
Aim 2. Structural Biology to guide hit and lead optimization.
Enzymology Core C will focus on solving 3D structures of polymerases and RNA helicases that are currently
not available to the scientific community. Priority will also be given to solving the structures of flavivirus and
alphavirus polymerases in complex with the nucleotide and non-nucleotide analog inhibitors to provide detailed
information on the inhibitor binding sites.
Aim 3. Support the Projects in detailed mechanism of action studies for lead compounds.
Functional assays will be employed to assess the inhibitory activity against the biologically relevant enzyme
target, such as measurements of the half maximal inhibitory concentration to determine compound potency.
Promising hits and leads will also be tested against homologous enzymes within the protein family as well as
distant enzymes to assess breadth and the potential for off-target activity. Enzymology Core C will provide an
array of state-of-the-art biochemical/biophysical approaches to provide MedChem Core D and the Projects with
information on the mechanisms associated with inhibition and resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enteroviral 2C protein as a therapeutic target
-
批准号:10609524
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Enteroviral 2C protein as a therapeutic target
-
批准号:10450381
-
项目类别:
-
资助金额:$78.96万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Optimizing nucleoside analog efficacy with novel exonuclease inhibitors
-
批准号:10514274
-
项目类别:
-
资助金额:$627.12万
-
财政年份:2022
-
负责人:CRAIG E. CAMERON
-
依托单位:
Contribution of IL-32 gene expression to viral persistence
-
批准号:10057016
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2020
-
负责人:CRAIG E. CAMERON
-
依托单位:
Contribution of IL-32 gene expression to viral persistence
-
批准号:10177863
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2020
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10021287
-
项目类别:
-
资助金额:$68.25万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
RNA-dependent RNA Polymerase
-
批准号:10017543
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10640512
-
项目类别:
-
资助金额:$4.82万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10447359
-
项目类别:
-
资助金额:$53.4万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:10331323
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2019
-
负责人:CRAIG E. CAMERON
-
依托单位:
Forms of HCV NS5A in vivo
-
批准号:8321157
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2012
-
负责人:CRAIG E. CAMERON
-
依托单位:
Forms of HCV NS5A in vivo
-
批准号:8432444
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2012
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:8072938
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2010
-
负责人:CRAIG E. CAMERON
-
依托单位:
RNA-dependent RNA Polymerase
-
批准号:8072954
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2010
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8321573
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8312798
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:8133089
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Mechanisms of RNA binding and remodeling proteins
-
批准号:7923334
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Phosphorimager Replacement
-
批准号:7595456
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2009
-
负责人:CRAIG E. CAMERON
-
依托单位:
Picornavirus Genome Replication
-
批准号:6836487
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2003
-
负责人:CRAIG E. CAMERON
-
依托单位:
海外基金